IPP Bureau
PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19
By IPP Bureau - April 18, 2022
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
Trivitron Healthcare sets up ultrasound manufacturing facility in India
By IPP Bureau - April 17, 2022
The ultrasound products manufactured in the new manufacturing facility will be sold under the brand name SonoRad, and are designed for large hospitals, healthcare institutions and individual radiology centres
Dr. Mansukh Mandaviya chairs celebrations of Ayushman Bharat health and wellness centres
By IPP Bureau - April 17, 2022
Dr. Mansukh Mandaviya launches a quarterly report on AB-HWCs, Guidelines on Human resources for health, Public Health Management Cadre’ Guidance for implementation and Indian Public Health Standards Guidelines; interacts with healthcare workers from across the country
Signia launches its first hearing impairment store in Delhi
By IPP Bureau - April 17, 2022
First of its kind interactive concept store ‘Brilliant Sound Galaxy (BSG)’ in the capital city
PLI scheme to achieve Aatma Nirbhar Bharat: Dr Manshukh Mandaviya
By IPP Bureau - April 17, 2022
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Jubilant Ingrevia augments its CDMO presence with Rs 270 crore contract
By IPP Bureau - April 17, 2022
Through the contract, the company will supply two key GMP intermediates for one of the 'patented drugs' of the innovator pharmaceutical customer
Evexia Lifecare's Vadodara API facility starts operations
By IPP Bureau - April 17, 2022
The company also plans to expand the facility
Sandoz launches generic brimonidine tartrate eyedrop in US
By IPP Bureau - April 15, 2022
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Lupin receives approval from USFDA for Desvenlafaxine extended-release tablets 25 mg
By IPP Bureau - April 15, 2022
The product will be manufactured at Lupin’s facility in Goa, India
Sinocompound announce new licencing agreement with Dalhousie university
By IPP Bureau - April 15, 2022
The DalPhos ligands were developed by Prof. Mark Stradiotto and his research team at the Department of Chemistry, Dalhousie University
Wockhardt Hospital launch support group for Parkinson patients and families
By IPP Bureau - April 15, 2022
Parkinson’s is not limited to old people, even youngsters can suffer from this disease
Ashland expands distribution deal with Univar for pharma ingredients
By IPP Bureau - April 15, 2022
Under the agreement, Univar Solutions customers in Brazil and Mexico will have access to Ashland's binders and disintegrants for solid dosage forms, matrix formers for modulated release drugs and coatings for regular and modulated release solid dosage forms
Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
By IPP Bureau - April 13, 2022
The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa
USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS
By IPP Bureau - April 13, 2022
An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)
HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies
By IPP Bureau - April 13, 2022
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
